Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RP-6306 是有效的、选择性的、口服活性的 PKMYT1 抑制剂 (IC50= 14 nM)。RP-6306 在细胞结合测定中显示出比其他激酶更高的选择性。RP-6306 显示出抗癌活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,330 | 现货 | ||
5 mg | ¥ 5,630 | 现货 | ||
10 mg | ¥ 7,870 | 现货 | ||
25 mg | ¥ 11,600 | 现货 | ||
50 mg | ¥ 15,700 | 6-8周 | ||
100 mg | ¥ 21,200 | 6-8周 | ||
1 mL * 10 mM (in DMSO) | ¥ 4,270 | 现货 |
产品描述 | RP-6306 is a potent, selective and orally active PKMYT1 inhibitor (IC50= 14 nM). RP-6306 exhibits a high degree of selectivity for PKMYT1 over other kinases in cellular binding assays. RP-6306 exhibits anticancer effects. |
靶点活性 | PKMYT1:14 nM |
体外活性 | RP-6306 (500 nM; 24h) treatment induced pan-γH2AX in HCC1569 breast cancer cell line indicates that tumor derived CCNE1 amplification also makes cells susceptible to DNA damage induction after PKMYT1 inhibition. RP-6306 treatment can selectively and accidentally activate CDK1 in CCNE1 overexpression cells, thus promoting early mitosis of cells undergoing DNA synthesis [2]. |
体内活性 | In the ovarian xenograft model (OVCAR3) amplified by CCNE1, RP-6306 (15, 50, and 300 ppm; oral; daily; for 21 days) significantly reduced tumor growth in OVCAR3 in a dose-dependent manner [1]. |
别名 | (S)-RP-6306 |
分子量 | 324.38 |
分子式 | C18H20N4O2 |
CAS No. | 2719793-90-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45.0 mg/mL (138.7 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.0828 mL | 15.414 mL | 30.828 mL | 77.0701 mL |
5 mM | 0.6166 mL | 3.0828 mL | 6.1656 mL | 15.414 mL | |
10 mM | 0.3083 mL | 1.5414 mL | 3.0828 mL | 7.707 mL | |
20 mM | 0.1541 mL | 0.7707 mL | 1.5414 mL | 3.8535 mL | |
50 mM | 0.0617 mL | 0.3083 mL | 0.6166 mL | 1.5414 mL | |
100 mM | 0.0308 mL | 0.1541 mL | 0.3083 mL | 0.7707 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
RP-6306 2719793-90-3 Cell Cycle/Checkpoint Wee1 RP 6306 RP6306 (S)-RP-6306 Inhibitor inhibitor inhibit